New antimicrobics for the pediatrician.
D000042:Absorption; D000328:Adult; D000658:Amoxicillin / Q000378:metabolism; D000667:Ampicillin / Q000031:analogs & derivatives / Q000378:metabolism / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000627:therapeutic use; D001390:Azlocillin; D002439:Cefotaxime / Q000627:therapeutic use; D002444:Cefuroxime / Q000627:therapeutic use; D002513:Cephamycins / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003493:Cyclacillin / Q000378:metabolism; D006118:Griseofulvin / Q000008:administration & dosage; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use; D007223:Infant; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000188:drug therapy*; D007654:Ketoconazole; D008802:Mezlocillin; D009070:Moxalactam; D010406:Penicillins / Q000627:therapeutic use; D010879:Piperazines / Q000627:therapeutic use
D000890:Anti-Infective Agents; D000935:Antifungal Agents; D002513:Cephamycins; D007093:Imidazoles; D010406:Penicillins; D010879:Piperazines; D006118:Griseofulvin; D003493:Cyclacillin; D000667:Ampicillin; D000658:Amoxicillin; C011674:bacampicillin; D001390:Azlocillin; D002439:Cefotaxime; D002444:Cefuroxime; D008802:Mezlocillin; D007654:Ketoconazole; D009070:Moxalactam